Dedifferentiated chondrosarcomas are aggressive variants of chondrosarcoma, associated
with poor outcomes. Tumor biphasism is the norm. The majority of these tumors are …

Background: There are very few published data on the survival of patients with
dedifferentiated chondrosarcoma, or, more specifically, on the efficacy and role of …

Abstract Purpose of Review The pathogenesis of dedifferentiated chondrosarcoma is
controversial, and no genetic abnormality has consistently been identified in the disease …

Simple Summary Dedifferentiated chondrosarcoma is a rare type of cancer that is very
aggressive and has a poor prognosis with poor survival rates. This disease can affect …

Background Dedifferentiated chondrosarcoma is a chondrosarcoma subtype associated
with high rates of recurrence and a poor prognosis. Others have proposed treatment of …

Simple Summary Dedifferentiated chondrosarcoma (DDCS) is a rare cancer that is
aggressive and leads to high patient mortality. There are limited data on the efficacy of …

Background. Dedifferentiated chondrosarcomas (DDCSs) are highly malignant tumors with
a dismal prognosis and present a significant challenge in clinical management. Methods. In …

Background and Objectives Dedifferentiated chondrosarcoma is a rare malignancy with
reported 5‐year overall survival rates ranging from 7% to 24%. The purpose of this …

Dedifferentiated chondrosarcoma (DDCS) is a high-grade subtype of chondrosarcoma with
the bimorphic histological appearance of a conventional chondrosarcoma component with …

Background: Dedifferentiated chondrosarcoma (DDC) accounts for a small proportion of
chondrosarcomas. They demonstrate aggressive behaviour with a high rate of local …